Bone Marrow TransplantationNeoplastic Stem CellsBone MarrowHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow CellsStem CellsGraft vs Host DiseaseStem Cell TransplantationTransplantation, AutologousHematopoietic Stem CellsBone and BonesTissue DonorsHematologic NeoplasmsCytomegalovirus InfectionsAntigens, CD24LeukemiaTransplantation ConditioningWhole-Body IrradiationImmunocompromised HostGraft SurvivalAnemia, AplasticHistocompatibility TestingTransplantationImmunosuppressive AgentsOpportunistic InfectionsCell DifferentiationAntigens, CD44Treatment OutcomeHistocompatibilityTime FactorsSpheroids, CellularMycosesRetrospective StudiesKidney TransplantationNeoplasmsAdult Stem CellsRecurrenceFlow CytometryRetinal DehydrogenaseEmbryonic Stem CellsCytomegalovirusPeripheral Blood Stem Cell TransplantationGraft RejectionTransplantation ChimeraLeukemia, Myeloid, AcuteAspergillosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, SCIDStem Cell NicheCell Line, TumorCell ProliferationImmunosuppressionAntigens, CDBone Marrow PurgingAldehyde DehydrogenaseMice, Inbred C57BLCyclosporineSurvival AnalysisBusulfanPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantsHematologic DiseasesFatal OutcomeCell SeparationCombined Modality TherapyHematopoiesisSide-Population CellsBone Marrow DiseasesBone RemodelingAntineoplastic AgentsSurvival RateGanciclovirPluripotent Stem CellsBone Marrow ExaminationAcute DiseaseCells, CulturedMultiple MyelomaHepatic Veno-Occlusive DiseaseBreast NeoplasmsBone Marrow NeoplasmsMice, Inbred NODAntigens, CD34Cell LineageDrug Resistance, NeoplasmPolymerase Chain ReactionCyclophosphamideEpithelial-Mesenchymal TransitionFollow-Up StudiesTransplantation, HeterologousHLA AntigensGlycoproteinsPrognosisAntineoplastic Combined Chemotherapy ProtocolsLymphocyte DepletionHematopoietic Stem Cell MobilizationAntifungal AgentsPneumonia, ViralHerpesvirus 6, HumanTumor Markers, Biological